Quantum-Si (NASDAQ:QSI) Cut to "Sell" at Wall Street Zen

Key Points

• Wall Street Zen downgraded Quantum-Si from “hold” to “sell,” although other analysts remain more positive. The stock has a consensus “hold” rating and an average price target of $2.50.
• Quantum-Si shares opened at $1.55 after rising 8.4%, with a market capitalization of approximately $339 million. The stock has traded between $0.69 and $3.10 over the past year.
• The company reported a quarterly loss of $0.11 per share, in line with estimates, and revenue of $0.34 million, slightly above expectations. Institutional investors own approximately 39.9% of Quantum-Si’s outstanding shares.

Quantum-Si (NASDAQ:QSI - Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a "hold" rating to a "sell" rating in a research report issued on Saturday, Wall Street Zen reports.

A number of other equities research analysts have also commented on the company. HC Wainwright reaffirmed a "buy" rating and set a $4.00 price target on shares of Quantum-Si in a research report on Tuesday. Alliance Global Partners reissued a "buy" rating on shares of Quantum-Si in a research note on Friday, August 14th. Finally, Weiss Ratings upgraded shares of Quantum-Si from a "sell (e+)" rating to a "sell (d-)" rating in a report on Thursday, September 24th. Two equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $2.50.

Quantum-Si Stock Up 8.4%

QSI opened at $1.55 on Friday. Quantum-Si has a 12 month low of $0.69 and a 12 month high of $3.10. The company has a fifty day simple moving average of $0.81 and a 200 day simple moving average of $0.88. The stock has a market cap of $339.26 million, a P/E ratio of -3.37 and a beta of 3.21.

Quantum-Si (NASDAQ:QSI - Get Free Report) last posted its earnings results on Thursday, August 13th. The company reported ($0.11) earnings per share for the quarter, hitting the consensus estimate of ($0.11). Quantum-Si had a negative return on equity of 47.12% and a negative net margin of 6,138.26%.The firm had revenue of $0.34 million for the quarter, compared to analyst estimates of $0.30 million. On average, equities research analysts expect that Quantum-Si will post -0.47 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Quantum-Si

A number of hedge funds and other institutional investors have recently bought and sold shares of QSI. IPG Investment Advisors LLC bought a new position in shares of Quantum-Si during the 2nd quarter worth approximately $27,000. WINTON GROUP Ltd bought a new stake in shares of Quantum-Si in the second quarter worth $67,000. Corient Private Wealth LP acquired a new position in Quantum-Si during the second quarter worth $34,000. Green Alpha Advisors LLC bought a new position in Quantum-Si in the second quarter valued at $41,000. Finally, Renaissance Technologies LLC bought a new position in Quantum-Si in the first quarter valued at $91,000. Institutional investors and hedge funds own 39.90% of the company's stock.

About Quantum-Si

Quantum-Si Incorporated NASDAQ: QSI is a life sciences technology company focused on advancing proteomics, the study of proteins and their roles in biological systems. The company develops tools intended to help researchers identify and analyze proteins at the single-molecule level, supporting applications in drug discovery, translational research and precision medicine.

Its primary offering is the Platinum platform, which combines an automated instrument, proprietary sequencing technology, consumables and software for protein analysis.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.